1 | according to the company | | | | | | | 5 | 0.21% |
2 | monday august 19 2024 | | | | | | | 4 | 0.17% |
3 | monday august 12 2024 | | | | | | | 3 | 0.13% |
4 | wednesday august 14 2024 | | | | | | | 3 | 0.13% |
5 | wednesday august 21 2024 | | | | | | | 3 | 0.13% |
6 | thursday september 5 2024 | | | | | | | 3 | 0.13% |
7 | the company said it | | | | | | | 2 | 0.08% |
8 | the new york times | | | | | | | 2 | 0.08% |
9 | were not announcedcontinue → | | | | | | | 2 | 0.08% |
10 | three predictions for 2023 | | | | | | | 2 | 0.08% |
11 | software says it has | | | | | | | 2 | 0.08% |
12 | university lab partners names | | | | | | | 2 | 0.08% |
13 | socal ip law group | | | | | | | 2 | 0.08% |
14 | helpt gets 850k in | | | | | | | 2 | 0.08% |
15 | partners names winners of | | | | | | | 2 | 0.08% |
16 | seatboost gets funding from | | | | | | | 2 | 0.08% |
17 | lab partners names winners | | | | | | | 2 | 0.08% |
18 | of a crypto dream | | | | | | | 2 | 0.08% |
19 | names winners of pitch | | | | | | | 2 | 0.08% |
20 | gets funding from iag | | | | | | | 2 | 0.08% |
21 | gets 850k in seed | | | | | | | 2 | 0.08% |
22 | 850k in seed investment | | | | | | | 2 | 0.08% |
23 | state railroad museum in | | | | | | | 2 | 0.08% |
24 | biotherapeutics names new ceo | | | | | | | 2 | 0.08% |
25 | nevada state railroad museum | | | | | | | 2 | 0.08% |
26 | monday september 23 2024 | | | | | | | 2 | 0.08% |
27 | to the company it | | | | | | | 2 | 0.08% |
28 | tuesday august 20 2024 | | | | | | | 2 | 0.08% |
29 | synthetic aperture radar sar | | | | | | | 2 | 0.08% |
30 | into space on a | | | | | | | 2 | 0.08% |
31 | it has partnered with | | | | | | | 2 | 0.08% |
32 | monday august 26 2024 | | | | | | | 2 | 0.08% |
33 | latigo biotherapeutics names new | | | | | | | 2 | 0.08% |
34 | nima farzan as its | | | | | | | 1 | 0.04% |
35 | farzan as its new | | | | | | | 1 | 0.04% |
36 | as its new chief | | | | | | | 1 | 0.04% |
37 | also providing its ticketing | | | | | | | 1 | 0.04% |
38 | is also providing its | | | | | | | 1 | 0.04% |
39 | it is also providing | | | | | | | 1 | 0.04% |
40 | latigo biotherapeutics which is | | | | | | | 1 | 0.04% |